| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 07/07/2005 | WO2005061433A2 Aminoalcohol derivatives |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | WO2005060692A2 Biphenyl compounds and methods |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/07/2005 | WO2005032471A3 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/07/2005 | US20050148796 Compounds and methods for preparing methanesulfonamides |
| 07/07/2005 | US20050148795 High yield and purity production of protease inhibitor intermediates; lower temperature; eliminates epoxide step, material handling losses and dust explosion issues |
| 07/07/2005 | US20050148786 Nontoxic; heat, moisture and light resistance; solubility; infrared absorption filter, optical information recording medium; antimony and arsenic free |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148608 Chymase enzyme inhibitors for drugs in vascular systems using sulfonylurea derivatives |
| 07/07/2005 | US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/07/2005 | US20050148473 Substituted sulfonylaminomethylbenzoic acid ( derivatives) and their preparation |
| 07/07/2005 | US20050147563 Imaging lymph nodes with a Gadolinium complex of 10-[2-hydroxy-4-aza-5-oxo-7-aza-7-(perfluorooctylsulfonyl)-nonyl]-1,4,7-tris (carboxymethyl)-1,4,7,10-tetraazacyclododecane; in vivo contrast media in nuclear spin tomography; blood-pool agents, lymphographic agents |
| 07/07/2005 | DE10357301A1 Verbindungen zur Modulation des Glykolyse-Enzym- und/oder Transaminase-Komplexes Compounds for modulation of the glycolytic enzyme and / or transaminase complex |
| 07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2548442A1 Benzoyl-substituted phenylalanine amides |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549306A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 07/06/2005 | CN1636004A Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/06/2005 | CN1634868A Substituted benzal cyclopentanone derivatives and their use |
| 07/06/2005 | CN1209352C Hydrazine derivatives |
| 07/06/2005 | CN1209348C Process for synthesizing 2, 4-di-(P-n-dodecyl-oxy-phenylsulfonamido) phenol |
| 07/05/2005 | US6914159 Which have excellent therapeutic effects against hypertension, congestive heart failure, angina pectoris or prostatic hypertrophy higher yield; isolation step i.e. chromatography is not needed |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058810A1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058299A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/30/2005 | WO2005016277A3 Arylsulfonamidobenzylic compounds |
| 06/30/2005 | US20050143595 Process for preparing fluorochemical monoisocyanates |
| 06/30/2005 | US20050143586 N-(di)nitrobenzenesulfonyl-protected-aziridine-2-carboxylic acid derivatives and intermediates; their preparation from haloalanine derivatives that may be N-(di)nitrobenzenesulfonyl-protected, preferably using metal 3,3-dimethyl-3-(optionally protected-amino)propynylides |
| 06/30/2005 | US20050143583 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 06/30/2005 | US20050143541 Water- and oil-repellent fluoroacrylates |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143354 Association of an antithrombotic and aspirin |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | EP1548866A1 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
| 06/29/2005 | EP1548750A1 Nonaqueous electrolyte, electrical double layer capacitors, and nonaqueous electrolyte secondary cells |
| 06/29/2005 | EP1546673A2 Novel green and orange fluorescent labels and their uses |
| 06/29/2005 | EP1546092A2 Agents for imaging and diagnostic methods using them |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1395550B1 Cycloalkenylsulfonamide derivatives |
| 06/29/2005 | EP0901459B1 Calcilytic compounds |
| 06/29/2005 | CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 06/29/2005 | CN1631876A Preparation of sodium probenecid and potassium probenecid, compound injection prepared by sodium probenecid, potassium probenecid and beta-lactam antibiotics, and use thereof |
| 06/29/2005 | CN1208375C Powdered rubber powder containing modified filler, its preparing method and its use |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 06/28/2005 | US6911476 Useful for potentiating glutamate receptor function therefore useful for treating a wide variety of conditions, such as psychiatric and neurological disorders |
| 06/28/2005 | US6911457 Diabetes imaging probes |
| 06/28/2005 | US6911451 Phenylalanine derivatives |
| 06/28/2005 | CA2114746C Substituted triazolinones |
| 06/23/2005 | WO2005057714A1 Electrolyte solution for secondary battery and secondary battery using same |
| 06/23/2005 | WO2005056521A1 Method of preparing optically pure phenethylamine derivatives |
| 06/23/2005 | WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 06/23/2005 | US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis |
| 06/23/2005 | US20050137236 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | US20050136332 Bis(dimethylamino)propylthiomethylium bis(trifluoromethanesulfonyl)imide; bis(dimethylamino)ethoxymethylium bis(trifluoromethanesulfonyl)imide; stable liquid state even at low temperatures; good conductivity |
| 06/22/2005 | EP1544193A1 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
| 06/22/2005 | EP1542964A2 Compounds for the treatment of alzheimer's disease |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6908947 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908719 Such as water soluble disodium-4,4'-diazido-2,2'-methylenedibenzenedisulfonate; improved ultraviolet radiation absorption in short wavelengths; color cathode ray tubes |
| 06/16/2005 | WO2005055286A2 Zwitterionic compounds and photovoltaic cells containing same |
| 06/16/2005 | WO2005054180A1 Antiamyloid phenylsulfonamides: n-cycloalkylcarboxamides derivatives |
| 06/16/2005 | WO2005054176A1 Peroxisome proliferator activated receptor modulators |
| 06/16/2005 | WO2005054174A2 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
| 06/16/2005 | WO2005053685A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 06/16/2005 | US20050131042 HIV protease inhibiting compounds |
| 06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |
| 06/16/2005 | CA2548129A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 06/16/2005 | CA2547212A1 Peroxisome proliferator activated receptor modulators |
| 06/15/2005 | EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/15/2005 | EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 06/15/2005 | EP1539685A1 Mcp-1 receptor antagonists and method of use thereof |
| 06/15/2005 | EP1539684A1 Benzenesulphonamides and process for their preparation |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |